Health Care/Hospital

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Headlines: * Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications.1  * Uses up to 75% less sample than 2.1 mm I.D. columns, conserving precious materials su...

2026-02-17 21:00 6389

sweelin® is now FDA GRAS Approved, Clearing the Path for Accelerated U.S. Commercialization

Amai Proteins announces a major milestone for sweelin® in the U.S. market. The U.S. FDA has completed its review of the GRAS (Generally Recognized as Safe) notice for sweelin® and confirmed it has no safety concerns regarding the use of sweelin® as a general sweetener. The GRAS Notice was submitt...

2026-02-17 20:13 4161

QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio

Agreement adds new analyzer platforms and expands assay menu across key international markets SAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to exp...

2026-02-16 14:00 5966

Community Med Care's "Love & Share" CNY Blessing Campaign Gives the Gift of TCM Healing and Brings Hope to Children in Need

HONG KONG, Feb. 16, 2026 /PRNewswire/ -- This Lunar New Year, Community Med Care is turning seasonal blessings into lasting impact. The charity's "Love & Share" CNY Blessing Campaign invites the public to support its flagship program, "Stand Up with Love: Angel Mission", which provides free Tradi...

2026-02-16 09:00 7886

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003

SUZHOU, China, Feb. 14, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005) of the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, for the treatment of ...

2026-02-14 20:58 11520

Visa-Free Policies Fuel New Trend in Medical Tourism: International Patients Praise Parkway in Shanghai

SHANGHAI, Feb. 14, 2026 /PRNewswire/ -- With the implementation of 144-hour visa-free transit across multiple cities in China, international visitors now enjoy significantly greater convenience. Recently, an intriguing trend has emerged: many foreign nationals arriving in Shanghai for business or...

2026-02-14 20:12 9277

SingHealth Opens Community MRI Centre at Dunearn Village in Collaboration with United Imaging

SINGAPORE, Feb. 14, 2026 /PRNewswire/ -- SingHealth, Singapore's largest public healthcare cluster, has opened a new MRI centre at Dunearn Village, marking its first MRI facility located outside a hospital campus and extending diagnostic imaging services into the community. Developed in collabor...

2026-02-14 20:00 10095

Omics Empower Hong Kong Launches Xenium™ In Situ Spatial Transcriptomics Services

HONG KONG, Feb. 13, 2026 /PRNewswire/ -- Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now available at its Hong Kong Science Park laboratory. Since the...

2026-02-13 14:00 5130

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value commercial partnerships in South Korea and Vietnam. NEW TAIPEI CITY, Feb. 13, 2026 /PRNewswire/...

2026-02-13 08:00 12081

Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan

* Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants presenting with weight gain failure such as very low birth weight (VLBW) in...

2026-02-12 20:00 5905

First clinical success! Yuanhua Tech, with its orthopaedic surgical robot with originally developed HX Orthopaedic-Specific Robotic Arm, breaks into the high-end medical equipment market

HONG KONG, Feb. 12, 2026 /PRNewswire/ -- On February 11, the orthopaedic surgical robot with originally developed HX Orthopaedic-Specific Robotic Arm, which was 100% homemade by Yuanhua Robotics, Perception and AI Technologies Ltd. (hereinafter referred to as "Yuanhua Tech"), saw its first clinic...

2026-02-12 19:34 3938

EDAN Connects Clinical Practice and Innovation at 2026 WHX Dubai and WHX Labs Dubai

DUBAI, UAE, Feb. 12, 2026 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ) participated in WHX Dubai (Formerly Arab Health) and WHX Labs Dubai (Formerly Medlab Middle East), presenting a comprehensive portfolio of medical solutions across multiple clinical dis...

2026-02-12 17:27 6071

Berlin Heals Successfully Raises Over 10M USD to Expand the New Less Invasive Approach to More Heart Failure Patients

ZUG, Switzerland, Feb. 12, 2026 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company focused on transformative therapies for heart failure, today announced the successful closing of a new financing round, raising over 10M USD from a combination of existing shareholders and new investors. Th...

2026-02-12 16:00 5213

AIA Singapore surpasses S$40 Billion in payouts over the last decade

Commemorating its 95th anniversary, the insurer reinforces its role as a vital safety net and wealth partner with new initiatives to fulfil promises across healthcare and long-term financial goals as well as deepen its engagement, contributing meaningfully to the nation's progress. SINGAPORE, Fe...

2026-02-12 13:36 6720

Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF

SHANGHAI, Feb. 12, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AK3280, a novel anti-fibrotic therapy for the treatment of idiopathic pulmona...

2026-02-12 12:18 5866

Australia and New Zealand's Skin Cancer Governance Gap Exposed: 40% of Organisations Never Assessed Workforce Risk Despite 84% Believing Duty of Care Applies

SYDNEY, Feb. 12, 2026 /PRNewswire/ -- A comprehensive new report on workplace skin cancer screening  in Australia and New Zealand has exposed a significant governance blind spot: whil...

2026-02-12 10:32 5212

KOALA ECO REFLECTS ON YEAR OF PURPOSE, GROWTH AS IT PLANS FOR CONTINUED SUCCESS IN 2026

SANTA BARBARA, Calif., Feb. 11, 2026 /PRNewswire/ -- Koala Eco , the mood-boosting wellness brand for cleaning, home and personal care founded by Jessica Bragdon and Paul Davidso...

2026-02-11 21:18 4970

Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH

SUZHOU, China and MÖLNDAL, Sweden, Feb. 11, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today announced that they have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceutica...

2026-02-11 19:31 6134

Witsbb Joins Hands with Multiple Parties to Launch New Standard in Nutrition Free from Common Allergens, Scientifically Safeguarding the Health of Allergy-Prone Infants

BEIJING, Feb. 11, 2026 /PRNewswire/ -- As the number of allergy-prone infants continues to climb globally, how to provide them with safe, nutritious, and reliable dietary support has become a pressing public health issue. Recently, at the "Scientific Care, Shared Growth" public welfare advocacy e...

2026-02-11 19:12 4825

ArisGlobal Announces XDI NavaX Data Intelligence, Three New Agents, and NavaX Translation

MADRID, Feb. 11, 2026 /PRNewswire/ -- ArisGlobal , an AI-first technology company at the forefront of Life Sciences and creator ofLifeSphere®,

2026-02-11 16:55 5897
1 ... 29303132333435 ... 541